<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02722070</url>
  </required_header>
  <id_info>
    <org_study_id>0657-15-HMO-CTIL</org_study_id>
    <nct_id>NCT02722070</nct_id>
  </id_info>
  <brief_title>Processing Integration in Neurological Patients Using fMRI</brief_title>
  <official_title>Processing Integration in Neurological Patients Using fMRI</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hadassah Medical Organization</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of the study is to explore and map brain areas involved in processing and
      perception in patients suffering from neurological pathologies and condition. The
      investigators hypothesize for example, that a change (compare to healthy subjects) in the
      perceptual maps and body representation could be detected and characterize in patients
      suffering from impairments of peripheral nerve conduction.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">March 2025</completion_date>
  <primary_completion_date type="Anticipated">March 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Hemodynamic responses by measurement of the Blood-oxygen-level dependence(BOLD) signal</measure>
    <time_frame>2 years</time_frame>
    <description>Distinct maps of sensory and multisensory representations related to certain disorders will be sassed by measurement of the Blood-oxygen-level dependence(BOLD) signal.</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Acute Inflammatory Demyelinating Polyradiculoneuropathy</condition>
  <condition>Stroke</condition>
  <condition>Anosognosia</condition>
  <condition>Central and Peripheral Neurodegenerative Pathologies</condition>
  <condition>Neuropsychiatric Conditions</condition>
  <arm_group>
    <arm_group_label>Healthy Controls</arm_group_label>
    <description>Age matched control for the various clinical groups</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Neurodegenerative patients</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Stroke patients</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Neuropsychiatric patients</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>3 Tesla Siemens Skyra MRI scanner</intervention_name>
    <description>Standardly used Magnetic resonance imaging (MRI) protocols, including resting state fMRI, task fMRI, T1 weighted imaging</description>
    <arm_group_label>Healthy Controls</arm_group_label>
    <arm_group_label>Neurodegenerative patients</arm_group_label>
    <arm_group_label>Stroke patients</arm_group_label>
    <arm_group_label>Neuropsychiatric patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients suffering from central and peripheral neurological pathologies and conditions
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosis of the investigated neuronal disease

        Exclusion Criteria:

          -  contraindication for MRI scan

          -  pregnancy

          -  refusal to participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Shahar Arzy, M.D, Ph.D</last_name>
    <phone>97226777741</phone>
    <email>shahar.arzy@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gregory Founshtein, M.s</last_name>
    <phone>972507794574</phone>
    <email>gregory.founshtein@mail.huji.ac.il</email>
  </overall_contact_backup>
  <results_reference>
    <citation>Arzy S, Overney LS, Landis T, Blanke O. Neural mechanisms of embodiment: asomatognosia due to premotor cortex damage. Arch Neurol. 2006 Jul;63(7):1022-5.</citation>
    <PMID>16831974</PMID>
  </results_reference>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 23, 2016</study_first_submitted>
  <study_first_submitted_qc>March 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 29, 2016</study_first_posted>
  <last_update_submitted>March 28, 2016</last_update_submitted>
  <last_update_submitted_qc>March 28, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polyradiculoneuropathy</mesh_term>
    <mesh_term>Agnosia</mesh_term>
    <mesh_term>Guillain-Barre Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

